KAI Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKAI Pharmaceuticals

KAI Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Parsabiv	Etelcalcetide	2017-02-07	2030-2034	Secondary hyperparathyroidism

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

chronic kidney failure

,

neoplasm metastasis

,

secondary hyperparathyroidism

,

hyperparathyroidism

,

chronic renal insufficiency

,

kidney diseases

,

left ventricular hypertrophy

,

,

,

disseminated intravascular coagulation

,

venous thromboembolism

,

thromboembolism

,

myocardial infarction

,

,

cardiovascular diseases

,

pathologic processes

Histone-arginine methyltransferase carm1

,

pharmacokinetics

,

,

,

ocular hypertension

,

open-angle glaucoma

,

multiple myeloma

,

plasma cell neoplasms

,

healthy volunteers/patients

,

erectile dysfunction

,

gastrointestinal neoplasms

,

neoplasm metastasis

,

,

renal cell carcinoma

,

,

breast neoplasms

,

,

pancreatic neoplasms

,

triple negative breast neoplasms

,

,

prostatic neoplasms

,

,

,

castration-resistant prostatic neoplasms

,

colorectal neoplasms

,

stomach neoplasms

,

,

biliary tract neoplasms

,

,

uterine cervical neoplasms

,

b-cell lymphoma

,

endometrial neoplasms

,

esophageal neoplasms

,

small cell lung carcinoma

,

transitional cell carcinoma

,

chronic hepatitis

,

,

gastrointestinal diseases

,

,

rna virus infections

,

digestive system diseases

,

viral hepatitis human

,

flaviviridae infections

,

general anesthesia

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

obstructive sleep apnea

,

sleep apnea syndromes

,

,

,

disorders of excessive somnolence

,

,

papillomavirus infections

,

vaginal neoplasms

,

vulvar neoplasms

,

condylomata acuminata

,

hodgkin disease

,

migraine disorders

,

atherosclerosis

,

uterine neoplasms

,

,

mullerian mixed tumor

,

,

esophageal squamous cell carcinoma

,

large b-cell lymphoma diffuse

,

neuroendocrine tumors

,

intestinal neoplasms

,

head and neck neoplasms

,

prostatic hyperplasia

,

,

muscular atrophy

,

,

,

urologic neoplasms

,

hepatocellular carcinoma

,

urinary bladder neoplasms

,

liver neoplasms

,

microsatellite instability

,

hidradenitis suppurativa

,

non-small-cell lung carcinoma

,

chronic hepatitis c

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

squamous cell carcinoma of head and neck

,

,

,

squamous cell carcinoma

,

,

,

urinary tract infections

,

,

keratoconjunctivitis sicca

,

dry eye syndromes

,

,

,

polycystic kidney diseases

,

,

spondylarthritis

,

,

axial spondyloarthritis

,

,

postherpetic neuralgia

,

,

,

,

,

ovarian neoplasms

,

,

acquired immunodeficiency syndrome

,

,

communicable diseases

,

,

,

,

,

,

kidney diseases

,

rheumatoid arthritis

,

ovarian epithelial carcinoma

,

hepatitis a virus

,

immunosuppression therapy

,

,

chronic renal insufficiency

,

chronic disease

,

drug-related side effects and adverse reactions

,

non-hodgkin lymphoma

,

follicular lymphoma

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use